Certain ergot peptide alkaloids administered to the nasal mucosa

Details Certain ergot peptide alkaloids administered to the nasal mucosa Certain ergot peptide alkaloids administered to the nasal mucosa

1981-12-08

1984-07-31

Schenkman, Leonard

Drug, bio-affecting and body treating compositions

Effervescent or pressurized fluid containing

Organic pressurized fluid

424250, A61K 31495

Patent

active

044629834

ABSTRACT:
The present invention provides a nasal or pulmonary pharmaceutical composition comprising as active agent a compound of formula I, ##STR1## wherein R.sub.1 is hydrogen or halogen,

REFERENCES:
patent: 3752814 (1973-08-01), Fluckiger et al.
patent: 3752888 (1973-08-01), Fluckiger et al.
patent: 3772299 (1973-11-01), Stadler et al.
patent: 3901891 (1975-08-01), Fehr et al.
patent: 4076715 (1978-02-01), Fehr et al.
Bradfield, Curr. Ther. 17, No. 11, 37-40, 1976.
Wilkinson, Brit. Med. J. 1971/1972, pp. 754-755.
Graham et al., New England J. of Med. 10/20/60, pp. 802-804.
Monthly Index of Medical Specialties (MIMS), 1974, pp. 47,4925D.
Freestone et al., Br. J. Clin. Pharmac. (1976), 3, pp. 827-830.
Strem et al., Annals of Allergy vol. 41, 9-1978, pp. 145-149.
Mehta. J. Indian Pract. 11, pp. 1019-1021 (1958).

Affiliated with

Also associated with

Rating

Certain ergot peptide alkaloids administered to the nasal mucosa does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Certain ergot peptide alkaloids administered to the nasal mucosa, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Certain ergot peptide alkaloids administered to the nasal mucosa will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-185249